Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine

Background While prophylactic human papillomavirus (HPV) vaccines will certainly reduce the incidence of HPV-associated cancers, these malignancies remain a major health issue. PDS0101 is a liposomal-based HPV therapeutic vaccine consisting of the immune activating cationic lipid R-DOTAP and HLA-unr...

Full description

Bibliographic Details
Main Authors: Claire Smalley Rumfield, Y Maurice Morillon II
Format: Article
Language:English
Published: BMJ Publishing Group 2020-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000612.full

Similar Items